Track the Sulaiman Alhabib stock price and the full insider trade history of the company, a listed equity based in Saudi Arabia. Shares are quoted on SA SA, under the supervision of Tadawul (CMA). Operating in the Health Care sector, Sulaiman Alhabib has recorded 3 insider filings. Market capitalisation: €77bn. The latest transaction was filed on 8 October 2023 (Board / executive change). All data is free.
Analysts rate Sulaiman Alhabib Buy (bullish), based on 13 analysts. Average price target: SAR 274.81.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.